See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Feb. 14, 2007

Alzheimer's Disease Rheumatoid Arthritis Cold Sores (Herpes Labialis Infections)

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Alzheimer's Disease

This is a clinical research trial of an investigational drug called AC-3933. Volunteers 55 or older who have mild-to-moderate Alzheimer's disease; are living with a caregiver; and who read, understand, and speak English may qualify. Volunteers will be excluded if they have had recent treatment with acethylcholinesterase inhibitors or an NMDA antagonist such as Aricept or Namenda, or are frequent users of products containing tobacco or caffeine.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat11.html.

-----

Rheumatoid Arthritis

This study will evaluate the effectiveness of an investigational medication in controlling symptoms of rheumatoid arthritis, when taken in addition to methotrexate. Participants must be at least 18, have active rheumatoid arthritis, be taking 10 to 25 mg of methotrexate per week, and have at least six tender joints and at least six swollen joints.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat132.html.

-----

Cold Sores (Herpes Labialis Infections)

Candidates for this study of a remedy to treat cold sores must be ages 18 to 80, have three or more cold sore outbreaks per year, be in good general health, and have no other dermatologic problems near the mouth.

The research site is in Wheat Ridge, Colo.

More information

Please see http://www.centerwatch.com/patient/studies/cat295.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.